Skip to main content

Table 4 Factors associated with increased mortality (N = 70)a

From: The Carpentier-Edwards Perimount Magna mitral valve bioprosthesis: intermediate-term efficacy and durability

 

Survivors (n = 62)

Nonsurvivors (n = 8)

P b

AF

14 (23 %)

5 (63 %)

0.02

Ischemic MR

1 (1.6 %)

3 (38 %)

0.03

IABP use

0 (0 %)

2 (25 %)

0.01

Cardiogenic shock

2 (3.2 %)

4 (50 %)

0.001

Cardiac arrest

1 (1.6 %)

2 (25 %)

0.03

Any renal failure

15 (24 %)

6 (75 %)

0.007

  1. AF atrial fibrillation IABP intraaortic balloon pump, MR mitral regurgitation
  2. a Continuous variables expressed as mean ± standard error of the mean (SE); categorical variables, as n (percentage)
  3. b Relationship between dichotomous variables and survival analyzed with 2-tailed Fisher exact tests